Drugs / Ankaferd
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06490653 | Oct 2024 → Oct 2025 | — | Ankara Ataturk Sanatorium Training and Research Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ankaferd | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06490653 ↗ |
| Known as | Blood Stopper | “Blood Stopper (Ankaferd)” NCT06490653 ↗ |
| Route | Intranasal | “sprayed through the bleeding side nostril” NCT06490653 ↗ |